As a consultant, hospitalists commonly risk stratify and offer risk reduction strategies for patients undergoing surgery. Effective perioperative pulmonary risk consultation requires hospitalists to identify patient- and procedure-related predictors for developing postoperative pulmonary complications and to propose strategies to reduce the risk. The following module will examine these topics and provide evidence-based risk reduction strategies. In addition, the role of routine preoperative spirometry and chest radiograph will be discussed.
After completing the module, the participant should be able to:
- Recognize the impact of postoperative pulmonary complications.
- Identify risk factors associated with higher incidence of postoperative pulmonary complications.
- Examine the role of routine preoperative spirometry and chest radiograph.
- Evaluate the evidence-based risk reduction strategies.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: November 15, 2008. Expiration date: November 15, 2010.
*Fellow in Pulmonary Care and Critical Care Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center, Tufts University, Boston, Massachusetts.
†Associate Professor of Medicine, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Disclaimer: The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Supported by an educational grant from Merck & Co., Inc.